Choose your region

Don't see your region/country
listed? Visit our global website

SEC filing details

Document Details

Form
Filing Date
Oct 22, 2026
Document Date
Oct 20, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Vertex Pharmaceuticals
Issuer
VERTEX PHARMACEUTICALS INC / MA
Filer
Brennan Daniel J.